Financials data is unavailable for this security.
View more
Year on year Merit Medical Systems Inc grew revenues 9.24% from 1.15bn to 1.26bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 26.70% net income growth from 74.52m to 94.41m.
Gross margin | 46.54% |
---|---|
Net profit margin | 9.02% |
Operating margin | 11.57% |
Return on assets | 5.58% |
---|---|
Return on equity | 9.45% |
Return on investment | 6.13% |
More ▼
Cash flow in USDView more
In 2023, Merit Medical Systems Inc increased its cash reserves by 872.86%, or 528.59m. Cash Flow from Financing totalled 559.27m or 44.48% of revenues. In addition the company generated 145.15m in cash from operations while cash used for investing totalled 175.35m.
Cash flow per share | 3.64 |
---|---|
Price/Cash flow per share | 27.00 |
Book value per share | 22.04 |
---|---|
Tangible book value per share | 10.27 |
More ▼
Balance sheet in USDView more
Current ratio | 6.24 |
---|---|
Quick ratio | 4.64 |
Total debt/total equity | 0.6248 |
---|---|
Total debt/total capital | 0.3846 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 25.21%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years) | 14.05 |
---|---|
EPS (TTM) vs TTM 1 year ago | 29.97 |